This article deeply analyzes the composition of common port miscellaneous fees for LCL shipping to Busan Port in South Korea, the influencing factors of fee levels, and provides practical suggestions for cost reduction, helping foreign trade enterprises optimize logistics costs.
Deeply introduce the sea transportation process of PE diaphragms exported from Shanghai to Busan, South Korea, covering key links such as customs declaration, insurance and document preparation.
Details the process and precautions for exporting disinfection products, especially for the US, EU and South Korean markets. Includes the classification of regulatory agencies, product registration, compliance obligations and response strategies for temporary policies.
The supervision and certification process for imported new energy vehicles in Singapore covers multiple departments and detailed technical regulations. This article provides an in - depth introduction to Singapores main regulatory agencies, applicable technical regulations, certification processes, and import procedures.
This article provides an in - depth introduction to South Koreas regulatory agencies, technical regulations, conformity assessment procedures, and import procedures for the import of new energy vehicles, providing a comprehensive import guide for enterprises.
The market access process for medical devices in South Korea is relatively complex, involving multiple steps and the participation of multiple departments. This article will briefly introduce the certification and registration processes required for exporting medical devices to South Korea.
出口韓國需要注意哪些關(guān)鍵事項(xiàng)？從KC認(rèn)證到物流安排，您是否了解如何確保產(chǎn)品符合韓國市場的法規(guī)和標(biāo)準(zhǔn)？本文詳細(xì)解析出口韓國的流程，幫助您避免常見問題，實(shí)現(xiàn)順利通關(guān)。
韓國食品藥品安全部（MFDS）于2023年6月26日，向WTO提交了G/TBT/N/KOR/1150號(hào)通知，計(jì)劃對《生物制劑等品種許可、審查規(guī)定》進(jìn)行修訂，以加強(qiáng)國內(nèi)生物制劑安全。修訂內(nèi)容包括對新出現(xiàn)的活菌制劑等名詞的定義，適用于設(shè)計(jì)質(zhì)量體系的質(zhì)量審核要求，藥理作用和臨床試驗(yàn)效果資料的“科學(xué)論文引用索引”范圍的擴(kuò)大，變更制造方法時(shí)，改善穩(wěn)定性試驗(yàn)資料的提交條件的更改，MFDS認(rèn)可的自行注射產(chǎn)品的風(fēng)險(xiǎn)管理計(jì)劃的強(qiáng)制性提交程序的新增，以及RNA和DNA疫苗評價(jià)標(biāo)準(zhǔn)的建立。鑒于中國是全球第二大生物制劑市場，此次修訂對我國出口企業(yè)有重要影響，企業(yè)需密切關(guān)注并適應(yīng)這些變化。
The Korea National Institute of Technology Standards issued Announcement No. 2023 - 0114, proposing to revise the Safety Standard for Electrical Products KC 10031 and establish safety standards for recycled lithium - ion batteries. This revision applies to secondary batteries and cells containing alkaline or other non - acidic electrolytes, and the products involved are electrical appliances and consumer products (recycled batteries).
? 2025. All Rights Reserved. 滬ICP備2023007705號(hào)-2 
PSB Record: Shanghai No.31011502009912
